Due to a production error, numbered headings were removed from this article but two citations of a numbered heading remained.
A correction has been made to the section Materials and Methods, subsection Shared TE-Analysis as a Tool to Estimate Donor-Reactive Memory CD4+ T-Helper Cells, Paragraph 2:
“In patients with preformed non-DSA, TEs derived from presensitizing HLA were calculated using PIRCHE-II and compared with calculated TEs derived from the donor HLA. We considered the shared TEs to be positive and estimated the presence of donor-reactive memory CD4+ T-helper cells if the two sets of TEs shared at least one pHLA, and negative if no pHLA were shared (Figure 1); for each non-DSA, TE counts shared with the donor HLA are shown in Supplementary Table 1.”
A correction has been made to the section Materials and Methods, subsection Shared BE Analysis, Paragraph 1:
“In patients with preformed non-DSA, similarly to the shared-TE analysis, the BEs derived from pre-sensitizing HLA were estimated using the HLAMatchmaker software and were compared with the calculated BEs derived from the donor HLAs. The shared BEs were determined as positive if the two sets of BEs shared at least one eplet, and negative if no eplets were shared; for each non-DSA, the BE counts shared with the donor HLA are shown in Supplementary Table 2.”
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
kidney transplantation, T cell epitope analysis, B cell epitope analysis, donor-specific antibody, PIRCHE-II
Citation
Frontiers Production Office (2022) Erratum: Clinical significance of shared T cell epitope analysis in early de novo donor-specific anti-HLA antibody production after kidney transplantation and comparison with shared B cell epitope analysis. Front. Immunol. 13:995022. doi: 10.3389/fimmu.2022.995022
Received
15 July 2022
Accepted
15 July 2022
Published
03 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.